Related content

Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer

By Keck Sara   Glencer Alexa C   Rugo Hope S  

Future Oncology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1383-1396

Future Medicine

Access to resources Recommend Favorite

The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells

By Vazquez-Martin Alejandro   Oliveras-Ferraros Cristina   Barco Sonia   Martin-Castillo Begoña   Menendez Javier  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 355-364

Springer Publishing Company

Access to resources Recommend Favorite

Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer

By Bartsch Rupert   Wenzel Catharina   Altorjai Gabriela   Pluschnig Ursula   Bachleitner-Hoffmann Thomas   Locker Gottfried   Rudas Margaretha   Mader Robert   Zielinski Christoph   Steger Guenther  

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 375-381

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo

By Zhu Yuanxi  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1349-1362

Springer Publishing Company

Access to resources Recommend Favorite

Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2positive breast cancer cells in vitro and in vivo

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1921-1926

Spandidos Publications

Access to resources Recommend Favorite